Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. Shapiro SB, Yin H, Yu OHY, Rej S, et al. BMJ 2025;388:e080679.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shapiro SB, Yin H, Yu OHY, Rej S, et al. Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. BMJ 2025;388:e080679.
PMID: 40010803